Document:

Exhibit 4.6

Exhibit 4.6

ARRIS RESOURCES INC.

2008 STOCK OPTION PLAN

PART 1

INTERPRETATION

1.01

Definitions.  In this Plan the following words and phrases shall have the following meanings, namely:

(a)

"Associate" means, where used to indicate a relationship with any person:

(i)

a partner, other than a limited partner, of that person;

(ii)

a trust or estate in which that person has a substantial beneficial interest or for which that person serves as trustee or in a similar capacity;

(iii)

a company in respect of which that person beneficially owns or controls, directly or indirectly, voting securities carrying more than 10% of the voting rights attached to all outstanding voting securities of the company; or

(iv)

a relative, including the spouse or child, of that person or a relative of that person’s spouse, where the relative has the same home as that person;

and for the purpose of this definition, "spouse" includes an individual who is living with another individual in a marriage-like relationship.

(b)

"Board" means the Board of Directors of the Company.

(c)

"Committee" means a committee of the Board appointed in accordance with this Plan or, if no such committee is appointed, the Board itself.

(d)

"Company" means Arris Resources Inc., and any successor company thereto as provided in this Plan.

(e)

"Consultant" means, in relation to the Company, an individual (or a company wholly-owned by an individual) who:

(i)

provides ongoing consulting services to the Company or an affiliate of the Company under a written contract;

(ii)

possesses technical, business or management expertise of value to the Company or an affiliate of the Company;

(iii)

spends a significant amount of time and attention on the business and affairs of the Company or an affiliate of the Company; and

(iv)

has a relationship with the Company or an affiliate of the Company that enables the individual to be knowledgeable about the business and affairs of the Company.

(f)

"Director" means any director of the Company or of any of its subsidiaries.

(g)

"Discounted Market Price" means the Market Price less the discount set forth below, subject to a minimum price of $0.10:

Closing Price

Discount

up to $0.50

    25%

$0.51 to $2.00

    20%

above $2.00

    15%

 

 

(h)

"Disinterested Shareholder Approval" means that the proposal must be approved by a majority of the votes cast at the shareholders’ meeting other than votes attaching to securities beneficially owned by Insiders and their Associates to whom shares may be issued pursuant to this Plan and, for purposes of this Plan, holders of non-voting and subordinate voting securities (if any) will be given full voting rights on a resolution which requires disinterested shareholder approval.

(i)

"Employee" means:

(i)

an individual who is considered an employee of the Company or any of its subsidiaries under the Income Tax Act (i.e. for whom deductions (income tax, UIC and CPP) must be made at source);

(ii)

an individual who is a full-time (i.e. 35 - 40 hours per week) dependent contractor, that is one who works full-time for the Company or any of its subsidiaries providing services normally provided by an employee and is subject to the same control and direction by the Company or its subsidiary over the detail and methods of work as an employee of the Company or its subsidiary, but for whom income tax deductions are not made at source; or

(iii)

a part-time dependent contractor, that is an individual who works for the Company or any of its subsidiaries on a continuing and regular basis for a minimum amount of time per week providing services normally provided by an employee and is subject to the same control and direction by the Company or its subsidiary over the details and methods of work as an employee of the Company or its subsidiary, but for whom income tax deductions are not made at source;

and includes Management Company Employees and Consultants.

(j)

"Exchange" means the Canadian Trading and Quotation System Inc., or such other Canadian stock exchange on which the Shares are listed for trading.

(k)

"Insider" means:

(i)

a director or senior officer of the Company;

(ii)

a director or senior officer of a person that is itself an insider or subsidiary of the Company; or

(iii)

a person that beneficially owns or controls, directly or indirectly, voting securities carrying more than 10% of the voting rights attached to all outstanding voting securities of the Company; or

(iv)

the Company itself if it holds any of its own securities.

(l )

"Management Company Employee" means an individual employed by a person  providing management services to the Company, which are required for the ongoing successful operation of the business enterprise of the Company, but excluding a person engaged in investor relations activities.

(m)

"Market Price" means, subject to the exceptions prescribed by the Exchange from time to time, the last closing price of the Company’s shares before the issuance of the required news release  disclosing the grant of options (but, if the policies of the Exchange provide an exception to such news release, then the last closing price of the Company’s shares before the grant of options).

(n)

"Officer" means any senior officer of the Company or of any of its subsidiaries as defined in the Securities Act (British Columbia).

(o)

"Plan" means this stock option plan as from time to time amended.

(p)

"Shares" means common shares without par value in the capital of the Company.

 

1.02

Gender.  Throughout this Plan, words importing the masculine gender shall be interpreted as including the female gender.

PART 2

PURPOSE OF PLAN

2.01

Purpose.  The purpose of this Plan is to provide incentive to Employees, Officers, Directors, Management Company Employee and Consultants who provide services to the Company and reduce the cash compensation the Company would otherwise have to pay.  This Plan will replace and supercede the prior 2004 stock option plan of the Company, and all options granted under such prior plan will be governed by this Plan.

PART 3

GRANTING OF OPTIONS

3.01

Administration.  This Plan shall be administered by the Board or, if the Board so elects, by a committee (consisting of not less than two (2) of its members) appointed by the Board. Any Committee shall administer the Plan on behalf of the Board in accordance with such terms and conditions as the Board may prescribe, consistent with this Plan.  Once appointed, the Committee shall continue to serve until otherwise directed by the Board.  From time to time, the Board may increase the size of the Committee and appoint additional members, remove members (with or without cause) and either appoint new members in their place or decrease the size of the Committee, fill vacancies however caused, or remove all members of the Committee and thereafter directly administer the Plan.  A majority of the members of the Committee shall constitute a quorum, and, subject to the limitations in this Part 3, all actions of the Committee shall require the affirmative vote of members who constitute a majority of such quorum.  Members of the Committee may vote on any matters affecting the administration of the Plan or the grant of options pursuant to the Plan, except that no such member shall act upon the granting of an option to himself (but any such member may be counted in determining the existence of a quorum at any meeting of the Committee during which action is taken with respect to granting options to him).

3.02

Committee's Recommendations.  The Board may accept all or any part of the recommendations of the Committee or may refer all or any part thereof back to the Committee for further consideration and recommendation.  Such recommendations may include, but not be limited to, the following:

(a)

resolution of questions arising in respect of the administration, interpretation and application of the Plan;

(b)

reconciliation of any inconsistency or defect in the Plan in such manner and to such extent as shall reasonably be deemed necessary or advisable to carry out the purpose of the Plan;

(c)

determination of the Employees, Officers and Directors (or their wholly-owned corporations) to whom, and when, options should be granted, as well as the number of Shares subject to each option;

(d)

determination of the terms and conditions of the option agreement to be entered into with any optionee, consistent with this Plan; and

(e)

determination of the duration and purpose of leaves of absence from employment which may be granted to optionees without constituting a termination of employment for purposes of the Plan.

3.03

Grant by Resolution.  The Board, on its own initiative or, if a Committee of the Board shall have been appointed for the purpose of administering this Plan, upon the recommendation of such Committee, may by resolution designate those Employees, Officers and  Directors to whom options should be granted.

3.04

Terms of Options.  The resolution of the Board shall specify the number of Shares that should be placed under option to each optionee, the price per Share to be paid upon exercise of the options, and the period during which such options may be exercised. The terms of an option may not be amended once issued under Exchange requirements. If an option is cancelled prior to the Expiry date, the Company shall not grant new options to the same individual within 30 days from the date of cancellation.

 

3.05

Written Agreements.  Every option granted under this Plan shall be evidenced by a written agreement between the Company and the optionee and, where not expressly set out in the agreement, the provisions of such agreement shall conform to and be governed by this Plan.  In the event of any inconsistency between the terms of the agreement and this Plan, the terms of this Plan shall govern.  

3.06

Regulatory Approvals.  The Board shall obtain all necessary regulatory approvals, which may be required under applicable securities laws or the rules or policies of the Exchange.  The Board shall also take reasonable steps to ensure that no options granted under the Plan, or the exercise thereof, shall violate the securities laws of the jurisdiction in which any optionee resides.

PART 4

CONDITIONS GOVERNING THE GRANTING AND EXERCISING OF OPTIONS

4.01

Exercise Price.  The exercise price of an option granted under this Plan is determined by the Board of Directors provided that it is not less than the price permitted by the Exchange. 

4.02

Expiry Date.  Each option shall, unless sooner terminated, expire on a date to be determined by the Board which will not be later than 5 years from the day the option is granted.

4.03

Different Exercise Periods, Prices and Number. The Board may, in its absolute  discretion, upon granting options under this Plan, specify different time periods following the dates of granting the options during which the optionees may exercise their options to purchase Shares and may designate different exercise prices and numbers of Shares in respect of which each optionee may exercise his option during each respective time period.

4.04

Number of Shares.  The number of Shares reserved for issuance to any one person pursuant to options granted under this Plan, together with any Shares reserved for issuance pursuant to options granted to that person during the previous 12 months, shall not exceed 5% of the issued and outstanding Shares at the time of granting of the options, provided that the aggregate number of options granted to each of the following categories of optionee:

(a)

Consultants; and

(b)

persons employed in investor relations activities on behalf of the Company;

must not exceed 2% of the outstanding Shares at the time of grant unless the Exchange permits otherwise.

4.05

Death of Optionee.  If an optionee dies prior to the expiry of his option, his legal representatives may, by the earlier of:

(a)

one year from the date of the optionee’s death (or such lesser period as may be specified by the Board at the time of granting the option); and

(b)

the expiry date of the option;

exercise any portion of such option.

4.06

Expiry on Termination or Cessation.  If an optionee ceases to be a director, officer, consultant, employee of the Corporation or its subsidiaries, or a Management Company Employee for any reason (other than death), he may exercise his option to the extent that he was entitled to exercise it at the date of such cessation, but only within 90 days after his ceasing to be a director, officer, consultant, employee or a Management Company Employee, unless such optionee was engaged in investor relations activities in which case, only within 30 days after the cessation of his services to the Corporation.

If an optionee ceases to be a director, officer, consultant, employee of the Corporation or its subsidiaries, or a Management Company Employee on account of cause, or terminated by regulatory sanction or by reason of judicial order, the options terminate immediately.

 

Nothing contained in the Plan, nor in any option granted pursuant to the Plan, shall as such confer upon any optionee any right with respect to continuance as a director, officer, consultant, employee or Management Company Employee of the Corporation or of any of its subsidiaries or affiliates.

4.07

Leave of Absence.  Employment shall be deemed to continue intact during any sick leave or other bona fide leave of absence if the period of such leave does not exceed 90 days or, if longer, for so long as the optionee’s right to reemployment is guaranteed either by statute or by contract.  If the period of such leave exceeds 90 days and the optionee’s reemployment is not so guaranteed, then his employment shall be deemed to have terminated on the ninety-first day of such leave.

4.08

Assignment.  No option granted under this Plan or any right thereunder or in respect thereof shall be transferable or assignable otherwise than by will or pursuant to the laws of succession except that, if permitted by the rules and policies of the Exchange, an optionee shall have the right to assign any option granted to him hereunder to a trust or similar legal entity established by such optionee.

4.09

Notice.  Options shall be exercised only in accordance with the terms and conditions of the agreements under which they are respectively granted and shall be exercisable only by notice in writing to the Company at its principal place of business.

4.10

Payment.  Subject to any vesting requirements described in each individual option agreement, options may be exercised in whole or in part at any time prior to their lapse or termination.  Shares purchased by an optionee on exercise of an option shall be paid for in full at the time of their purchase (i.e. concurrently with the giving of the requisite notice).

4.11

Share Certificate.  As soon as practicable after due exercise of an option, the Company shall issue a share certificate evidencing the Shares with respect to which the option has been exercised.  Until the issuance of such share certificate, no right to vote or receive dividends or any other rights as a shareholder shall exist with respect to such Shares, notwithstanding the exercise of the option.  No adjustment will be made for a dividend or other right for which the record date is prior to the date the share certificate is issued, except as provided in Part 6 hereof.

4.12

Vesting.  Vesting, if any, and other terms and conditions relating to such options shall be determined by the Board or the Committee in accordance with Exchange requirements. 

4.13

Bona Fide Optionee.

Each individual option agreement providing for the grant of options under this Plan to an Employee, Consultant or Management Company Employee will contain a representation by the Company that the optionee is a bona fide Employee, Consultant or Management Company Employee, as the case may be, of the Company or of a subsidiary of the Company.

PART 5

RESERVE OF SHARES FOR OPTIONS

5.01

Maximum Number of Shares Reserved Under Plan.  The aggregate number of Shares which may be subject to issuance pursuant to options granted under this Plan shall not exceed 10% of the issued and outstanding shares of the Company from time to time at the date of grant (including all options granted by the Company prior to the adoption of the Plan).  This number is subject to adjustment in accordance with Part 6 hereof.  In addition, all options granted outside of this Plan, which are in existence on the effective date of this Plan, shall be counted as if granted under this Plan.  The terms of this Plan shall govern such pre-existing options.

If any option granted under this Plan is exercised or expires or otherwise terminates for any reason, the number of Shares in respect of which the option is exercised or expired or terminated shall again be available for the purposes of the Plan.

5.02

Sufficient Authorized Shares to be Reserved.  Whenever the Memorandum or Articles of the Company limit the number of authorized Shares, a sufficient number of Shares shall be reserved by the Board to satisfy the exercise of options granted under this Plan or otherwise.  Shares that were the subject of options that have lapsed or terminated without having been exercised shall thereupon no longer be in reserve and may once again be subject to an option granted under this Plan.

 

5.03

Disinterested Shareholder Approval.  Unless Disinterested Shareholder Approval is obtained, under no circumstances shall this Plan, together with all of the Company’s other previously established or proposed stock options, stock option plans, employee stock purchase plans or any other compensation or incentive mechanisms involving the issuance or potential issuance of Shares, result in or allow at any time:

(a)

the number of Shares reserved for issuance pursuant to options granted to Insiders exceeding 10% of the outstanding Shares at the time of granting the options;

(b)

the issuance to Insiders, within a one year period, of a number of Shares exceeding 10% of the outstanding Shares at the time of granting the options; or

(a)

the issuance to any one Insider and such Insider’s Associates, within a one year period, of a number of Shares exceeding 5% of the outstanding Shares at the time of granting the options; or

(d)

any reduction in the exercise price of options granted to any person who is an  Insider at the time of the proposed reduction. 

PART 6

CHANGES IN SHARES

6.01

Share Consolidation or Subdivision.  In the event that the Shares are at any time subdivided or consolidated, the number of Shares reserved for option and the price payable for any Shares that are then subject to option shall be adjusted accordingly.

6.02

Stock Dividend.  In the event that the Shares are at any time changed as a result of the declaration of a stock dividend thereon, the number of Shares reserved for option and the price payable for any Shares that are then subject to option may be adjusted by the Board to such extent as they deem proper in their absolute discretion.

6.03

Reorganization.  Subject to any required action by its shareholders, if the Company shall be a party to an reorganization, merger, dissolution or sale or lease of all or substantially all of its assets, whether or not the Company is the surviving entity, the option shall be adjusted so as to apply to the securities to which the holder of the number of shares of capital stock of the Company subject to the option would have been entitled by reason of such reorganization, merger or sale or lease of all or substantially all of its assets, provided however that the Company may satisfy any obligations to an optionee hereunder by paying to the said optionee in cash the difference between the exercise price of all unexercised options granted hereunder and the fair market value of the securities to which the optionee would be entitled upon exercise of all unexercised options, regardless of whether all conditions of exercise relating to continuous employment have been satisfied.  Adjustments under this paragraph or any determinations as to the fair market value of any securities shall be made by the Board, or any committee thereof specifically designated by the Board to be responsible therefor, and any reasonable determination made by the said Board or committee thereof shall be binding and conclusive.

6.04

Rights Offering.  If at any time the Company grants to the holders of its capital stock rights to subscribe for and purchase pro rata additional securities of the Company or of any other corporation or entity, there shall be no adjustments made to the number of shares or other securities subject to the option in consequence thereof and the said stock option of the optionee shall remain unaffected.

PART 7

EXCHANGE'S RULES AND POLICIES APPLY

7.01

Exchange's Rules and Policies Apply.  This Plan and the granting and exercise of any options hereunder are also subject to such other terms and conditions as are set out from time to time in the rules and policies on stock options of the Exchange and any securities commission having jurisdiction and such rules and policies shall be deemed to be incorporated into and become a part of this Plan. In the event of an inconsistency between the provisions of such rules and policies and of this Plan, the provisions of such rules and policies shall govern.

 

PART 8

AMENDMENT OF PLAN

8.01

Board May Amend.  Subject to the requirements for shareholder approval pursuant Section 5.03, the Board may, by resolution, amend or terminate this Plan, but no such amendment or termination shall, except with the written consent of the optionees concerned, affect the terms and conditions of options previously granted under this Plan which have not then been exercised or terminated.

PART 9

MISCELLANEOUS PROVISIONS

9.01

Effective Date of Plan.  This Plan was adopted by the Board of Directors and became effective on May 21, 2008.

9.03

Use of Proceeds.  Proceeds from the sale of Shares pursuant to the options granted and exercised under the Plan shall constitute general funds of the Company and shall be used for general corporate purposes.

9.04

Headings.  The headings used in this Plan are for convenience of reference only and shall not in any way affect or be used in interpreting any of the provisions of this Plan.

9.05

No Obligation to Exercise.  Optionees shall be under no obligation to exercise options granted under this Plan.20-F

Exhibit 4.3 

AGREEMENT

          This
Agreement (the “Agreement”) is dated as of December 31, 2007, by and between
Optibase Ltd., an Israeli company (the “Company”), and the funds identified in
Schedule 1 attached hereto (the “Funds”).  

          WHEREAS,
the Funds collectively hold and desire to sell an aggregate of 629,591 ordinary
shares NIS 1.40 par value each of Scopus Video Networks Ltd. (the “Scopus Shares”);  

          WHEREAS,
the Funds desire to sell and transfer the Scopus Shares to the Company; 

          WHEREAS,
the Company desires to acquire the Scopus Shares from the Funds; and 

          WHEREAS,
the Company desires to pay an aggregate of US$ 3,903,464 to the Funds in
consideration for the Company’s acquisition of the Scopus Shares. 

          NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this
Agreement, and for other good and valuable consideration the receipt and
adequacy of which are hereby acknowledged, the Company and the Funds agree as
follows:   

ARTICLE 1.

CLOSING

          1.1.
          Closing.
Subject to the terms and conditions set forth in this Agreement, at the closing
of the transactions (“Closing”), (i) each of the Funds shall sell and
transfer to the Company and the Company shall acquire from each of the Funds
the number of Scopus Shares set forth opposite such Fund’s name in Schedule
1; and (ii) the Company shall pay to each of the Funds the cash
consideration set forth opposite such Fund’s name in Schedule 1. The
Closing shall take place at the offices of Gross, Kleinhendler, Hodak, Berkman
& Co., One Azrieli Center, Tel Aviv, 67021 on the date hereof or at such
other time as the parties may agree. 

          1.2.          Closing
Deliveries. At the Closing, the following events and transactions shall occur,
which events and transactions shall be deemed to take place simultaneously and
no event or transaction shall be deemed to have been completed or any document
delivered until all such events and transactions have been completed and all
required documents delivered: (i) the Company shall wire transfer to each of
the Funds the cash consideration set forth opposite such Fund’s name in Schedule
1 via bank accounts provided to it in advance; and (ii) each of the Funds
shall wire via a broker account of the Company provided to it in advance such
number of Scopus Shares set forth opposite to such Fund’s name in Schedule 1.

ARTICLE 2. 

REPRESENTATIONS AND WARRANTIES

          2.1.          Representations
and Warranties of the Company. The Company hereby makes the following
representations and warranties to each of the Funds: 

                          (a)          Authorization;
Enforcement. The Company has the requisite corporate power and authority to
enter into and to consummate the transactions contemplated by this Agreement
and otherwise to carry out its obligations hereunder. The execution and
delivery of this Agreement by the Company and the consummation by it of the
transactions contemplated hereby have been duly authorized by all necessary
actions on the part of the Company and no further action is required by the
Company in connection therewith. This Agreement has been duly executed and
delivered by the Company and constitutes the valid and binding obligation of
the Company enforceable against the Company in accordance with its terms. 

                          (b)          No
Consents. No approval, consent, waiver of any governmental authority or any
other third party is necessary for the execution of this Agreement and the
consummation by the Company of the transaction contemplated hereby. 

                          (c)          Sufficiency
of Representations and Warranties. Except for the representations and
warranties expressly included in Section 2.2 below, the Company is purchasing
the Scopus Shares AS IS, without reliance on any other representations and/or
warranties made by the Funds or anyone on their behalf. 

                          (d)          Sophistication
of the Company; Financial Resources. The Company has the requisite
knowledge and experience in financial and business matters to be capable of
evaluating the merits and risks of an investment, and of investing, in Scopus
Video Networks Ltd. (“Scopus”) as contemplated by this Agreement. The Company
at the execution of this Agreement has sufficient financial resources to
consummate this Agreement and the transaction contemplated hereby.  

                          (e)          Finders’
Fees. The Company has not employed or made any agreement with any broker,
finder or similar agent or any person or firm, which will result in the
obligation of the Funds to pay any finder’s fee, brokerage fees or commission
or similar payment in connection with the transactions hereunder. 

                          (f)          Current
Holdings in Scopus. The Company currently holds 3,725,223 Ordinary Shares. 

                          (g)          No
Conflicts. The execution and delivery of this Agreement, the transfer of
the Scopus Shares to the Company and the consummation by the Company of the
transactions contemplated hereby do not and will not (i) conflict with or
violate any provision of the memorandum or articles of association of the
Company, or (ii) conflict with, or constitute a default (or an event that with
notice or lapse of time or both would become a default) under, or give to
others any rights of termination, amendment, acceleration or cancellation (with
or without notice, lapse of time or both) of, any agreement or other
understanding to which the Company is a party, or (iii) result in a violation
of any law, rule, regulation, order, judgment, injunction, decree or other
restriction of any court or governmental authority to which such Company is
subject (including securities laws and regulations). 

          2.2.          Representations
and Warranties of the Funds. Each of the Funds hereby represents and
warrants to the Company as follows: 

                          (a)          Authorization;
Enforcement. Such Fund has the requisite power and authority to enter into
and to consummate the transactions contemplated by this Agreement and otherwise
to carry out its obligations hereunder. The execution and delivery of this
Agreement by such Fund and the consummation by it of the transactions
contemplated hereby have been duly authorized by all necessary actions on the
part of such Fund and no further action is required by such Fund in connection
therewith. This Agreement has been duly executed and delivered by such Fund and
constitutes the valid and binding obligation of such Fund enforceable against
such Fund in accordance with its terms. 

                          (b)          Current
Holdings in Scopus. Each of the Funds currently holds an aggregate of
Ordinary Shares as set forth opposite such Fund’s name in Schedule 1 under the
caption “No. of Shares Held Prior to Sale”.  

                          (c)          Ownership
of the Scopus Shares. Each of the Funds is, and at the Closing shall be,
the sole record and beneficial owner of the Scopus Shares held by it, free and
clear of any claim, lien, security interest, right of first refusal, preemptive
right, right of participation, any similar right to participate in the
transactions contemplated by this Agreement or with regard to the Scopus Shares
held by it or any other encumbrance or restriction whatsoever (collectively,
“Liens”). At the Closing, each of the Funds shall transfer and deliver to the
Company the Scopus Shares held and owned by it, free and clear of any and all
Liens.  

                          (d)          No
Conflicts. The execution and delivery of this Agreement, the transfer of
the Scopus Shares to the Company and the consummation by each of the Funds of
the transactions contemplated hereby do not and will not (i) conflict with or
violate any provision of the memorandum or articles of association, bylaws or
other organizational or charter documents of such Fund, or (ii) conflict with,
or constitute a default (or an event that with notice or lapse of time or both
would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation (with or without notice, lapse of time
or both) of, any agreement or other understanding to which such Fund is a
party, or (iii) result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental
authority to which such Fund is subject (including securities laws and
regulations). No legal or administrative suit, action, arbitration or other
proceeding or governmental investigation is pending, or to such Fund’s
knowledge is threatened against such Fund, that would encumber or affect the
title or interest of the Company in or to the Scopus Shares or that would
prevent or affect the consummation of the transactions contemplates by this
Agreement or the ownership by the Company of the Scopus Shares. 

                          (e)          No
Consents. No approval, consent, waiver of any governmental authority or any
other third party is necessary for the execution of this Agreement and the
consummation by such Fund of the transaction contemplated hereby. 

                          (f)          U.S.
Securities Laws. As of the date of the Closing, such Fund is not subject to
any resale restrictions under the U.S. Securities Act of 1933, as amended with
respect to the Scopus Shares hereby sold by it. 

ARTICLE 3. 

CONDITIONS PRECEDENT TO CLOSING

          3.1.          Conditions
Precedent to the Obligations of Funds. The obligations of the Funds to
transfer the Scopus Shares at the Closing are subject to the satisfaction or
waiver by the Funds of each of the following conditions: 

                          (a)          Representations
and Warranties. The representations and warranties of the Company contained
herein shall be true and correct in all material respects as of the date when
made and as of the Closing as though made on and as of such date; 

                          (b)          No
Injunction. No statute, rule, regulation, executive order, decree, ruling
or injunction shall have been enacted, entered, promulgated or endorsed by any
court or governmental authority of competent jurisdiction that prohibits the
consummation of any of the transactions contemplated by this Agreement; and 

                          (c)          Termination.
This Agreement shall not have been terminated in accordance with Article 4. 

          3.2.          Conditions
Precedent to the Obligations of the Company. The obligations of the Company
to acquire the Scopus Shares and transfer the consideration at the Closing are
subject to the satisfaction or waiver by the Company of each of the following
conditions: 

                          (a)          Representations
and Warranties. The representations and warranties of the Funds contained
herein shall be true and correct in all material respects as of the date when
made and as of the Closing as though made on and as of such date; 

                          (b)          No
Injunction. No statute, rule, regulation, executive order, decree, ruling
or injunction shall have been enacted, entered, promulgated or endorsed by any
court or governmental authority of competent jurisdiction that prohibits the
consummation of any of the transactions contemplated by this Agreement; 

                          (c)          Termination.
This Agreement shall not have been terminated in accordance with Article 4. 

ARTICLE 4.

TERMINATION

This Agreement
may be terminated prior to Closing: 

                          (a)          by
written agreement of all parties hereto; or 

                          (b)          by
the Company or each of the Funds upon written notice to the other, if the
Closing shall not have taken place by 17:00, Israel local time on January 31,
2008; provided, that the right to terminate this Agreement under this
sub-section (b) shall not be available to a party whose failure to comply with
its obligations under this Agreement has been the cause of or resulted in the
failure of the Closing to occur on or before such time.  

ARTICLE 5.

MISCELLANEOUS

          5.1.          Fees
and Expenses. Each party shall pay the fees and expenses that it incurs
incident to the negotiation, preparation, execution, delivery and performance
of this Agreement. 

          5.2.          Entire
Agreement. This Agreement contains the entire understanding of the parties
with respect to the subject matter hereof and supersedes all prior agreements,
understandings, discussions and representations, oral or written, with respect
to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules. 

          5.3.          Amendments;
Waivers  No provision of this Agreement may be waived or amended except in
a written instrument signed by all parties. No waiver of any default with
respect to this Agreement shall be deemed to be a continuing waiver in the
future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of
either party to exercise any right hereunder in any manner impair the exercise
of any such right. 

          5.4.          Successors
and Assigns; Counterparts. This Agreement shall be binding upon and inure
to the benefit of the parties and their successors and permitted assigns. None
of the Funds may assign this Agreement or any rights or obligations hereunder
without the prior written consent of the Company. This Agreement may be
executed in two or more counterparts, all of which when taken together shall be
considered one and the same agreement. 

          5.5.          Governing
Law. This Agreement, its performance and interpretation shall be governed
by the substantive law of the State of Israel, exclusive of its choice of law
rules. The competent courts and tribunals situated in Tel Aviv, Israel shall
have sole and exclusive jurisdiction in any dispute or controversy arising out
of or relating to this Agreement. 

          5.6.          No
Third Party Beneficiaries. This Agreement is made solely for the benefit of
the parties, and no third party shall have any right hereunder or be deemed a
beneficiary hereof. 

          5.7.          Press
Releases. The Funds undertake not to issue any press release or other
publication in respect thereof, without the prior consent of the Company, which
consent shall not be unreasonably withheld. 

          5.8.          Survival.
The representations and warranties contained herein shall survive the Closing
and the delivery of the Scopus Shares. 

          5.9.          Notices.
All notices, demands and other communications to be given and delivered under
and by reason of this Agreement shall be in writing and shall be deemed to have
been given when delivered personally to the recipient and sent to the recipient
by a reputable express courier service (charges prepaid), mailed to the
recipient by certified or registered mail, return receipt requested and postage
prepaid, or sent by telecopier. Such notices, demands and other communications
shall be sent to the Company at 2 Gav Yam Center Herzliya 46120, Israel
(telecopier number +972 (3) - 7624717, Attention: Amir Philips, and to each of
the Funds at the address (or telecopier number) set forth opposite to such Fund’s
name in Schedule 1 attached hereto or at such other address (or telecopier
number) or to the attention of such other person as a recipient party may have
specified by prior written notice to the sending party. 

[remainder of page intentionally left blank] 

          IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly
executed by their respective authorized signatories as of the date first
indicated above. 

	
 

	
 

	
 

	
 

	
OPTIBASE
  LTD.

	
 

	
 

	
 

	
 

	
/s/ Tom Wyler

	
 

	

	
 

	
Name:

	
Tom Wyler

	
 

	
Title:

	
Chief Executive
  Officer

	
 

	
 

	
 

	
 

	
/s/ Amir Philips

	
 

	

	
 

	
Name: 

	
Amir Philips

	
 

	
Title:

	
Chief
  Financial Officer

	
 

	
 

	
 

	
 

	
PITANGO
  VENTURE CAPITAL FUND III (ISRAELI INVESTORS) LP

	
 

	
 

	
 

	
 

	
/s/ Isaac Hillel

	
 

	

	
 

	
Name:

	
Isaac Hillel

	
 

	
Title:

	
Managing
  General Partner

	
 

	
 

	
 

	
 

	
/s/ Aaron Mankovski

	
 

	

	
 

	
Name:

	
Aaron
  Mankovski

	
 

	
Title:

	
Managing
  General Partner

	
 

	
 

	
 

	
 

	
PITANGO
  VENTURE CAPITAL FUND III (ISRAELI SUB) LP

	
 

	
 

	
 

	
 

	
/s/ Isaac Hillel

	
 

	

	
 

	
Name:

	
Isaac Hillel

	
 

	
Title:

	
Managing
  General Partner

	
 

	
 

	
 

	
 

	
/s/ Aaron Mankovski

	
 

	

	
 

	
Name:

	
Aaron
  Mankovski

	
 

	
Title:

	
Managing
  General Partner

	
 

	
 

	
 

	
 

	
PITANGO
  VENTURE CAPITAL FUND III (ISRAELI SUB) NON-Q LP

	
 

	
 

	
 

	
 

	
/s/ Isaac Hillel

	
 

	

	
 

	
Name:

	
Isaac Hillel

	
 

	
Title:

	
Managing
  General Partner

	
 

	
 

	
 

	
 

	
/s/ Aaron Mankovski

	
 

	

	
 

	
Name:

	
Aaron
  Mankovski

	
 

	
Title:

	
Managing
  General Partner

	
 

	
 

	
 

	
 

	
PITANGO
  PARALLEL INVESTOR FUND III (ISRAEL), LP

	
 

	
 

	
 

	
 

	
/s/ Isaac Hillel

	
 

	

	
 

	
Name:

	
Isaac Hillel

	
 

	
Title:

	
Managing
  General Partner

	
 

	
 

	
 

	
 

	
/s/ Aaron Mankovski

	
 

	

	
 

	
Name:

	
Aaron
  Mankovski

	
 

	
Title:

	
Managing
  General Partner

	
 

	
 

	
 

	
 

	
PITANGO
  PRINCIPALS FUND III (ISRAEL) LP

	
 

	
 

	
 

	
 

	
/s/ Isaac Hillel

	
 

	

	
 

	
Name:

	
Isaac Hillel

	
 

	
Title:

	
Managing
  General Partner

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
/s/ Aaron Mankovski

	
 

	

	
 

	
Name:

	
Aaron
  Mankovski

	
 

	
Title:

	
Managing
  General Partner

	
 

	
 

	
 

	
 

	
PITANGO
  VENTURE CAPITAL FUND III TRUSTS 2000 LTD.

	
 

	
 

	
 

	
 

	
/s/ Isaac Hillel

	
 

	

	
 

	
Name:

	
Isaac Hillel

	
 

	
Title:

	
Managing
  General Partner

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
/s/ Aaron Mankovski

	
 

	

	
 

	
Name:

	
Aaron
  Mankovski

	
 

	
Title:

	
Managing
  General Partner

Schedule I

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
Fund

	
 

	
Address

	
 

	
No. of Shares Held by the Fund Prior to Sale

	
 

	
No. of Shares to be Sold to Optibase

	
 

	
Consideration to be Paid by Optibase at Closing to the Fund

	
 

	

	
 

	

	
 

	

	
 

	

	
 

	

	
 

	
Pitango Venture Capital
  Fund

  III (Israeli Investors) LP

	
 

	
11 Hamenofim St., Bldg. B

  Herzliya 46725, Israel

  Attention: Daphna Cohen-Gersht

	
 

	
242,642

	
 

	
103,642

	
 

	
$

	
642,580

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
Pitango Venture Capital
  Fund

  III (Israeli Sub) LP

	
 

	
 

	
 

	
890,110

	
 

	
380,205

	
 

	
$

	
2,357,271

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
Pitango Venture Capital
  Fund

  III (Israeli Sub) Non-Q LP

	
 

	
 

	
 

	
82,286

	
 

	
35,148

	
 

	
$

	
217,918

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
Pitango Parallel Investor
  Fund

  III (Israel), LP

	
 

	
 

	
 

	
164,771

	
 

	
70,381

	
 

	
$

	
436,362

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
Pitango Principals Fund III

  (Israel) LP

	
 

	
 

	
 

	
31,383

	
 

	
13,405

	
 

	
$

	
83,111

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
Pitango Venture Capital
  Fund

  III Trusts 2000 Ltd.

	
 

	
 

	
 

	
62,765

	
 

	
26,810

	
 

	
$

	
166,222

	
 

	
 

	
 

	
 

	
Total:  1,473,957

	
 

	
Total:  629,591 

	
 

	
Total:  $ 3,903,464

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00144-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00144-of-00352.parquet"}]]